Compare Lustrum:Kringle Pharma,Inc.:4884

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Kringle Pharma,Inc. Go to web site 4884 Medicals 東証グロース September 1, 2000 2020.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Kringle Pharma,Inc. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Kringle Pharma,Inc. Balance Sheet 2024年9月期 Kringle Pharma,Inc. Balance Sheet 2023年9月期 Kringle Pharma,Inc. Balance Sheet 2022年9月期 Kringle Pharma,Inc. Balance Sheet 2021年9月期 Kringle Pharma,Inc. Balance Sheet 2020年9月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date September 30, 2024 September 30, 2023 September 30, 2022 September 30, 2021 September 30, 2020
Cash and Cash Equivalents
(Percent)
2,313up
(83.9%)up
2,136down
(81.6%)down
2,756up
(85.9%)up
2,138up
(81.1%)down
2,103
(89.5%)
Other Current AssetsHelp
(Percent)
443down
(16.0%)down
481up
(18.4%)up
451down
(14.1%)down
497up
(18.9%)up
247
(10.5%)
Tangible Fixed AssetsHelp
(Percent)

-
0
-
0
-
0
-
0
-
Intangible Fixed AssetHelp
(Percent)
0
-
0
-
0
-
0
-
0
-
Investments and OthersHelp
(Percent)
1up
(0.0%)up
1
(0.0%)up
1up
(0.0%)down
1down
(0.0%)down
1
(0.0%)
Total AssetsHelp
(Percent)
2,757
(100%)
2,619
(100%)
3,209
(100%)
2,636
(100%)
2,350
(100%)
Total Current LiabilitiesHelp
(Percent)
649up
(23.5%)up
597up
(22.8%)up
420up
(13.1%)up
129down
(4.9%)down
162
(6.9%)
Total Long-term LiabilitiesHelp
(Percent)

-
0
-
0
-
0
-
0
-
Shareholder's EquityHelp
(Percent)
2,108up
(76.5%)down
2,022down
(77.2%)down
2,789up
(86.9%)down
2,506up
(95.1%)up
2,189
(93.1%)
Total LiabilitiesHelp
(Percent)
2,757
(100%)
2,619
(100%)
3,209
(100%)
2,636
(100%)
2,350
(100%)

Kringle Pharma,Inc. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Kringle Pharma,Inc. Profit and Loss Account 2024年9月期 Kringle Pharma,Inc. Profit and Loss Account 2023年9月期 Kringle Pharma,Inc. Profit and Loss Account 2022年9月期 Kringle Pharma,Inc. Profit and Loss Account 2021年9月期 Kringle Pharma,Inc. Profit and Loss Account 2020年9月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date September 30, 2024 September 30, 2023 September 30, 2022 September 30, 2021 September 30, 2020
Amount of Sales
(Percent)
80
(100%)
69
(100%)
392
(100%)
290
(100%)
468
(100%)
Total Sales
(Percent)
80
(100%)
69
(100%)
392
(100%)
290
(100%)
468
(100%)
Cost of SalesHelp
(Percent)

-

-
88up
(22.6%)down
72
(24.7%)
0
-
Other Costs and RevenueHelp 836down
(1,045.1%)down
923up
(1,333.4%)up
635up
(162.1%)down
519down
(179.2%)up
585
(125.2%)
Total CostsHelp 836 923 724 591 585
Net RevenueHelp
-

-
303up
(77.4%)up
218down
(75.3%)down
468
(100.0%)
Earnings Before TaxHelp -755up
(-943.3%)up
-853down
(-1,231.3%)down
-330down
(-84.3%)up
-300down
(-103.4%)down
-116
(-24.9%)
Net IncomeHelp -756up
(-945.1%)up
-854down
(-1,233.4%)down
-332down
(-84.7%)up
-301down
(-103.9%)down
-118
(-25.2%)
当期純利益 -756 -854 -332 -301 -118

Kringle Pharma,Inc. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Kringle Pharma,Inc. Cash Flow Statement 2024年9月期 Kringle Pharma,Inc. Cash Flow Statement 2023年9月期 Kringle Pharma,Inc. Cash Flow Statement 2022年9月期 Kringle Pharma,Inc. Cash Flow Statement 2021年9月期 Kringle Pharma,Inc. Cash Flow Statement 2020年9月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date September 30, 2024 September 30, 2023 September 30, 2022 September 30, 2021 September 30, 2020
Operating Cash Flow(OFC)Help
(Percent)
-661up
(-78.9%)up
-689down
(-85.1%)down
16up
(2.6%)up
-561down
(-66.0%)down
-146
(-10.9%)
Investing Cash Flow(ICF)Help
(Percent)
-121down
(-14.5%)up
-121up
(-14.9%)up
-254
(-41.1%)down
-254
(-29.9%)

-
Financing Cash FlowHelp
(Percent)
838up
(100.0%)up
69down
(8.5%)down
603up
(97.4%)up
596
(70.1%)up
596
(44.5%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
0
-
-0
(0.0%)
0
-
254
(29.9%)

-
Net Increase and Decrease in Cash and Cash Equivalentsn 56up
(6.6%)up
-741down
(-91.5%)down
365up
(58.9%)up
35down
(4.1%)down
1,936
(144.6%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Kringle Pharma,Inc.

Company where related level is highHelp

MIKASA SEIYAKU CO.,LTD.
Mochida Pharmaceutical Co.,Ltd.
Fuso Pharmaceutical Industries, Ltd.
Delta-Fly Pharma,Inc.
Sanko Junyaku Co.,Ltd.
TMS Co.,Ltd.
MEDICAL & BIOLOGICAL LABORATORIES CO.
Kyowa Kirin Co.,Ltd.
Immuno-Biological Laboratories Co., Ltd.
D.Western Therapeutics Institute, Inc.